World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   7691 records for 1296 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
Not recruitingNCT02410343
Study of TV-1106 in Growth Hormone-Deficient Adults
30/03/2015
Not recruitingNCT02410356
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
30/03/2015
RecruitingNCT02394028
A Study of the Safety and Efficacy of Etrolizumab in Patients With Moderately to Severely Active Crohn's Disease
27/02/2015
Not recruitingNCT02375971
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
18/02/2015
RecruitingNCT02367794
A Phase III Study of MPDL3280A (Anti-PD-L1) in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-paclitaxel Compared With Carboplatin + Nab-paclitaxel in Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)
13/02/2015
Not recruitingNCT02367040
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
12/02/2015
AuthorisedEUCTR2014-003041-10-EE
This study is to find out if ranibizumab is safe and effective compared to laser therapy in preterm babies with ROP, a condition of abnormal blood vessel (arteries and veins) development in the eyes
11/02/2015
AuthorisedEUCTR2014-000925-19-AT
A study investigating the efficacy and safety of copanlisib versus placebo in patients with rituximab-refratory indolent non-Hodgkin's lymphoma.
Recruitment statusMain IDPublic titleDate of registration
Not recruitingNCT02369016Phase III Copanlisib in Rituximab-refractory iNHL17/02/2015
03/02/2015
AuthorisedEUCTR2014-001042-24-LV
A blinded study to compare the safety and immune response in adults of Abbott’s Candidate Quadrivalent Influenza and Abbott's known Trivalent Influenza Vaccine.
23/01/2015
AuthorisedEUCTR2014-001487-35-LT
A study to evaluate whether a new inhaled medicine (combination of beclometasone plus formoterol plus glycopyrronium) works as well as a combination of licensed medicines (combination of fluticasone plus vilanterol and tiotropium) in patient with chronic obstructive pulmonary disease.
22/01/2015
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history